Stephen Baskin is the Managing Partner of the firm's Washington, D.C. office. His practice focuses on patent infringement and other complex litigation.

Mr. Baskin represents a wide variety of companies, from large multinational corporations to small technology and start up companies, and various other entities in patent disputes. He has been involved in defending a financial institution in one of the most significant patent cases in the history of the financial services industry, and was involved in representing a research foundation against a licensee in a multimillion dollar dispute over patented technology involving the treatment of a rare blood disease. Mr. Baskin is regularly involved in representing companies in disputes related to electrical, mechanical and business method patents.

Mr. Baskin also has significant experience representing financial services, software, technology and construction companies in other complex litigation, including the enforcement of trade secrets and non-competition agreements, high stakes complex business litigation and managing internal corporate investigations. He was significantly involved in representing a publicly traded company in a bid rigging antitrust investigation where amnesty was sought and obtained with the Antitrust Division of the Department of Justice, and also represented a professional football player in a National Football League steroid investigation that involved corresponding congressional and U.S. Attorney investigations.

Mr. Baskin has been interviewed on several occasions about the successful growth of the firm's D.C. office during the past several years. In 2008, Mr. Baskin was named as one of the up and coming "Top Lawyers" in Washington, D.C. by the Washington Business Journal.